Safety and Risk of Pharmacotherapy

ISSN 2312-7821 · 2619-1164

Publisher: FSBI Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation

Scopus · Q2Open Access

Is Safety and Risk of Pharmacotherapy indexed in Scopus? Yes — actively indexed in Scopus, coverage 2021–2026, best quartile Q2, CiteScore 0.7.

Is Safety and Risk of Pharmacotherapy in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

Is Safety and Risk of Pharmacotherapy open access? Yes — it is an open-access journal, listed in DOAJ.

0.7

CiteScore 2025

Scopus

Best quartile

55th percentile

Indexed in

major indexes

ScopusElsevier Scopus

Status

Active

Coverage

2021–2026

Source type

Journal

Open access

Yes

CiteScore

0.7

Best quartile

Q2 · 55th pctile

Subject area	Rank	Pctile	Q
Pharmacology (nursing)	5 / 10	55th	Q2
Health Professions (miscellaneous)	63 / 101	38th	Q3
Pharmacy	35 / 52	33rd	Q3
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)	39 / 57	32nd	Q3

View this source on Scopus.com

Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)

Not listed in Web of Science.

ABDCAustralian Business Deans Council 2025

Not listed in ABDC.

DOAJDirectory of Open Access Journals (live)

Checking DOAJ…

FT50Financial Times research list

Not listed in FT50.

UT DallasUTD top-100 business research

Not listed in UT Dallas.

ONOS · APC coveredOne Nation One Subscription (Govt of India)

Not in the ONOS APC-supported list.

Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Official sources & links

Journal website ↗ Scopus source ↗ DOAJ ↗

Related journals

Explore this journal in the interactive dashboard →

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.